Venn Life Sciences Share Discussion Threads

[investordave] 22/11/2016 11:20

I see someone has just sold £50 of shares. It has always struck me as bizarre when people do this. Why bother for such a low amount?

[investordave] 21/11/2016 16:02

LBO - So don't invest if you don't trust the company. It's quite simple really.

[lbo] 21/11/2016 14:33

The same thing was said about Alltracel yet investors were fleeced. Looking at the Warrants, options and salaries again not much has changed

[chadders] 19/11/2016 12:18

Investing is a constant risk v return balancing act. AIM is very risky but it hasn't changed much in recent years- good and bad. You especially can't afford to be impatient with your AIM stocks. My portfolio at the moment is 80% AIM and at the moment I'm well up in 10 and well down in 2 and a bit down (7%) in VENN.

I never buy on a whim. If I like the look of a stock I place it on my watch list for a while before investing.

Although down at the moment I believe VENN is a winner, good honest management in a dream sector with a growing reputation and client list.

[investordave] 18/11/2016 08:48

rivaldo - and yet still no buyers.. V odd. I'm going to add at the end of the month when funds available.

[rivaldo] 18/11/2016 08:29

Great to see the sale of Innovenn proceeding smoothly and now completed.

The IPO process takes some time - perhaps 2-3 months for a small cap like Integumen - so hopefully it may happen before Xmas, otherwise I can see it floating in early January.

I expect the share price to move up nicely from here. With 2.39p EPS forecast this year, and 2.68p EPS next year, we now have a core business on almost a single-figure P/E, with cash in the bank, and a sizeable stake in a company about to IPO for a few more £m's.

[lbo] 18/11/2016 07:50

Very vague statement as usual. It's like Alltracel all over again when shareholders suffered massive losses from when it IPO to eventually being sold for a fraction of that while others walked away with salaries and exercised cheap share options.

[chadders] 17/11/2016 16:29

Makes no difference if you're in it long term. A no brainer for me and expecting nothing but good news from here on in e.g. Innoven sale completion, more focus, greater efficiency, more contracts and improving profitability etc. I'm a holder so DYOR peeps.

[investordave] 17/11/2016 15:56

Still being sold off in small chunks by PIs and no buys for quite a few days now. Where are all the buyers?

[cumnor] 08/11/2016 22:44

Huge deal this, not so much in monetary terms (which for Venn is quite decent) but the fact they chose Venn over a well served market of clinical trial providers. Must have a decent, ongoing, reputation within the industry so augurs well. Surprised at restrained share price reaction-added.

[investordave] 08/11/2016 13:06

rivaldo - quite right. Hopefully the latest results will stimulate some more buying interest soon.

[rivaldo] 08/11/2016 08:23

Great news - and since it starts immediately it will contribute to this year's results too, so the 2016 numbers should be extremely impressive given what we know.

[mrphiljones] 08/11/2016 08:00

patviera
8 Nov '16 - 07:43 - 673 of 675 0 0
Directors buy
Two days later big contract win
Hmmmmm


Very odd IMHO.....

[cheshire man] 08/11/2016 07:54

Excellent :-)

[chadders] 08/11/2016 07:53

Back on track. Oversold recently following the over reaction to the "disappointment" of the Innovenn sale. Should see a climb back to previous levels and upwards and onwards from there. Good company with solid management - my new CRX.

[patviera] 08/11/2016 07:43

Directors buyTwo days later big contract winHmmmmm

[investordave] 08/11/2016 07:40

With this good news, I'll be getting back in this morning, probably for 5p more than I sold at. Wish I had sat tight now. Oh well, won't make the same mistake again. Will be in for the long haul from today.

[battlebus2] 08/11/2016 07:18

2.5 million contract win...

[investordave] 08/11/2016 06:49

Adam. If you're right, VENN sounds like a very good investment at the current levels. Time will tell of course.

[adamb1978] 07/11/2016 23:09

InvestorDave

I disagree. Innovenn was loss-making so dilutive to EPS and therefore, unless you were to apply a multiple to the group and then add on a value for Innovenn on top, you were undervaluing the company.

Once Innovenn is sold, EPS automatically increases given its losses go away and VENN will be distributing their shareholding in the new entity to shareholders, so you have that as well

Adam